Recent systemic assessments and clinical analyses have found that CD4+T lymphocytopenia is a strong risk factor for lymphoma development in SS, with the strongest predictor being a lowered CD4+/CD8+ T cell ratio [26, 44]. Here, CD4 is linked to lymphoma.